It was reported on Tuesday that CATO SMS, a company focused on specialised clinical research solutions, has acquired United States-based Array Biostatistics.
This move is to help CATO SMS expand its full-service biostatistical consulting, analysis and programming capabilities. CATO SMS is to concentrate on building its team of senior biostaticians and statistical programmers as part of its expansion plans.
Array will continue to be led by Sandy Ferber, chief executive officer of Array. Ferber will also lead CATO SMS' overall biometrics offering.
Harbour BioMed partner raises USD225m to advance neoadjuvant immuno-oncology therapy porustobart
Kazia Therapeutics doses first patient in paediatric AT/RT study
Fusion Antibodies secures Canadian patent for OptiMAL
Revvity to acquire Human Cell Design to expand metabolic disease drug discovery capabilities
Biophytis expands BIO101 obesity study to assess weight regain
THX Pharma secures European patent for Batten-1 in juvenile Batten disease
Orphalan commences Phase 3 study of trientine therapy in Wilson disease
ZAGENO named Frost & Sullivan's 2026 North American Life Sciences E-Commerce Company of the Year
Pharvaris reports Phase 3 success for deucrictibant XR in HAE prophylaxis
Sky Labs presents clinical research outcomes for ring-type blood pressure monitor CART